With operations in 35 countries and 2,800 employees, Alvogen offers a broad range of medications for the treatment of conditions in oncology, cardiology, respiratory, neurology, and gastroenterology. Their lines of business include generic sales and marketing, product development, contract manufacturing, and contract research. They are dedicated to making high-quality medicines more accessible around the world and have four manufacturing and development hubs in the U.S., Romania, Korea, and Taiwan.